4 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Relapse Leukemia: new trials by email Literature Review of Relapse Leukemia trials Research Report on Relapse Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Allogeneic CD19 CAR-T cells - Relapse Leukemia, Refractory Leukemia | Phase 1 / Phase 2 | Unknown | Shenzhen University General Hospital | 20 | 2021-02-05 | 2021-12-20 |
| Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia Decitabine, mBU/CY and ATG, mBU/CY - Stem Cell Transplant Complications, Relapse Leukemia | Phase 2 / Phase 3 | Unknown | Peking University People's Hospital | 55 | 2018-12-01 | 2019-05-29 |
| Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) GLIDE - Hematologic Cancer, Relapse Leukemia | Phase 1 / Phase 2 | Unknown | Ciusss de L'Est de l'Île de Montréal | 20 | 2017-02-06 | 2017-12-06 |
| Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia Cladribine, G-CSF, Aclarubicin - Acute Myeloid Leukemia, Relapse Leukemia | Phase 2 | Unknown | Sun Yat-sen University | 48 | 2016-01-01 | 2019-08-20 |
Leukemia (2) · Leukemia, Myeloid, Acute (2) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Leukemia (2) · Leukemia, Myeloid (2) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1)
Aclarubicin (1) · Cladribine (1) · Cytarabine (1) · Decitabine (1) · Granulocyte Colony-Stimulating Factor (1) · aclacinomycins (1)
Ciusss de L'Est de l'Île de Montréal (1) · Peking University People's Hospital (1) · Shenzhen University General Hospital (1) · Sun Yat-sen University (1)
China (3) · Canada (1)
Denis-Claude Roy, MD PhD (1) · Li Yu, Dr (1) · Liang Wang, M.D. (1) · Silvy Lachance, MD (1) · Xiao-Jun Huang (1)